Nifty
:
11075.90
Sensex
:
37104.39
93.10 (0.85%)
-209.45 (-0.56%)
Nifty
Sensex
:
:
11075.90
37104.39
93.10 (0.85%)
-209.45 (-0.56%)

Parnax Lab Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 506128 | NSE: Not Listed

NSE BSE
27.70
13-Sep-2019
  • Open
  • High
  • Low
  • Previous Close
  •  27.50
  •  28.90
  •  25.60
  •  26.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  10
  •  0.32
  •  55.00
  •  21.70

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 23.56
  • 6.01
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 58.58
  • N/A
  • 0.66

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 62.59%
  • 2.08%
  • 32.28%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.05%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 9.00
  • 14.02

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 49.43
  • 3.30
  • -0.47

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 61.41
  • -15.63
  • -24.87

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.63
  • 3.36
  • 3.98

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1076.12
  • 1656.54
  • 2725.79

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Net Sales
20.66
23.06
-10.41%
20.14
0.00
0.00
23.31
0.00
0.00
42.27
0.00
0.00
Expenses
18.59
20.62
-9.84%
19.41
0.00
0.00
21.42
0.00
0.00
37.11
0.00
0.00
EBITDA
2.07
2.45
-15.51%
0.72
0.00
0.00
1.89
0.00
0.00
5.16
0.00
0.00
EBIDTM
10.02%
10.62%
3.59%
0.00%
8.12%
0.00%
12.20%
0.00%
Other Income
0.08
0.06
33.33%
0.68
0.00
0.00
0.53
0.00
0.00
0.84
0.00
0.00
Interest
1.02
0.92
10.87%
1.06
0.00
0.00
1.04
0.00
0.00
0.87
0.00
0.00
Depreciation
1.06
0.87
21.84%
1.04
0.00
0.00
0.94
0.00
0.00
0.96
0.00
0.00
PBT
0.07
0.72
-90.28%
-0.70
0.00
-
0.44
0.00
0.00
4.16
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.05
0.00
0.00
0.00
0.00
0.00
PAT
0.07
0.72
-90.28%
-0.70
0.00
-
0.39
0.00
0.00
4.16
0.00
0.00
PATM
0.35%
3.13%
-3.48%
0.00%
1.67%
0.00%
9.85%
0.00%
EPS
0.09
0.85
-89.41%
-0.82
0.00
-
0.46
0.00
0.00
4.88
0.00
0.00

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
106.38
105.50
94.81
71.18
102.75
68.57
55.82
93.06
Net Sales Growth
361.32%
11.28%
33.20%
-30.73%
49.85%
22.84%
-40.02%
 
Cost Of Goods Sold
50.87
54.90
49.94
37.80
66.91
40.30
32.29
76.47
Gross Profit
55.51
50.60
44.87
33.38
35.83
28.27
23.53
16.59
GP Margin
52.18%
47.96%
47.33%
46.90%
34.87%
41.23%
42.15%
17.83%
Total Expenditure
96.53
95.76
82.41
61.21
90.73
60.29
48.38
92.72
Power & Fuel Cost
-
2.99
3.27
2.11
2.45
1.96
1.68
1.59
% Of Sales
-
2.83%
3.45%
2.96%
2.38%
2.86%
3.01%
1.71%
Employee Cost
-
11.68
9.22
7.46
7.72
6.87
5.74
5.60
% Of Sales
-
11.07%
9.72%
10.48%
7.51%
10.02%
10.28%
6.02%
Manufacturing Exp.
-
13.96
14.24
9.04
8.66
6.92
5.65
5.02
% Of Sales
-
13.23%
15.02%
12.70%
8.43%
10.09%
10.12%
5.39%
General & Admin Exp.
-
6.29
4.36
3.27
2.82
2.36
1.73
1.75
% Of Sales
-
5.96%
4.60%
4.59%
2.74%
3.44%
3.10%
1.88%
Selling & Distn. Exp.
-
4.20
0.98
0.95
1.34
1.57
1.28
0.94
% Of Sales
-
3.98%
1.03%
1.33%
1.30%
2.29%
2.29%
1.01%
Miscellaneous Exp.
-
1.74
0.41
0.57
0.83
0.30
0.01
1.35
% Of Sales
-
1.65%
0.43%
0.80%
0.81%
0.44%
0.02%
1.45%
EBITDA
9.84
9.74
12.40
9.97
12.02
8.28
7.44
0.34
EBITDA Margin
9.25%
9.23%
13.08%
14.01%
11.70%
12.08%
13.33%
0.37%
Other Income
2.13
1.34
0.99
0.70
0.81
1.10
0.96
0.64
Interest
3.99
4.32
4.92
4.29
4.40
3.65
3.82
4.25
Depreciation
4.00
3.74
3.75
2.90
2.99
2.10
1.93
1.90
PBT
3.97
3.02
4.71
3.48
5.44
3.64
2.64
-5.16
Tax
0.05
1.97
1.02
0.97
1.18
0.91
0.93
-2.37
Tax Rate
1.26%
65.23%
21.66%
27.87%
21.69%
26.69%
35.23%
45.93%
PAT
3.92
1.06
3.68
2.50
4.25
2.48
1.71
-2.80
PAT before Minority Interest
3.91
1.06
3.69
2.51
4.26
2.49
1.71
-2.80
Minority Interest
-0.01
0.00
-0.01
-0.01
-0.01
-0.01
0.00
0.00
PAT Margin
3.68%
1.00%
3.88%
3.51%
4.14%
3.62%
3.06%
-3.01%
PAT Growth
444.44%
-71.20%
47.20%
-41.18%
71.37%
45.03%
-
 
Unadjusted EPS
4.61
1.24
4.34
2.95
5.01
2.93
2.01
-3.29

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
32.51
31.37
27.64
25.14
20.89
18.41
18.04
Share Capital
8.50
8.50
8.50
8.50
8.50
8.50
8.50
Total Reserves
24.01
22.86
19.14
16.63
12.39
9.90
9.53
Non-Current Liabilities
17.60
17.65
22.81
26.62
21.56
16.99
11.76
Secured Loans
11.70
12.57
13.72
16.45
16.73
12.36
8.44
Unsecured Loans
5.00
4.51
8.59
9.18
3.55
3.54
4.46
Long Term Provisions
0.23
0.38
0.00
0.14
0.09
0.00
0.00
Current Liabilities
37.19
36.45
28.90
31.02
40.89
24.89
29.55
Trade Payables
7.68
7.67
3.09
9.27
22.39
9.19
13.04
Other Current Liabilities
14.47
13.12
11.27
8.06
6.99
7.61
2.97
Short Term Borrowings
15.03
15.65
13.05
12.09
10.32
7.40
13.04
Short Term Provisions
0.02
0.01
1.50
1.59
1.19
0.70
0.50
Total Liabilities
87.37
85.53
79.40
82.83
83.38
60.32
59.38
Net Block
43.70
47.32
37.85
36.10
35.70
32.71
33.31
Gross Block
50.47
51.07
58.88
54.55
51.15
46.06
44.73
Accumulated Depreciation
6.77
3.75
21.03
18.45
15.45
13.35
11.42
Non Current Assets
50.91
54.66
48.84
44.85
37.48
35.39
37.60
Capital Work in Progress
0.00
0.00
2.44
0.95
0.55
0.00
0.00
Non Current Investment
0.23
0.34
0.91
0.86
0.86
0.73
0.71
Long Term Loans & Adv.
6.98
7.00
7.64
6.94
0.37
1.94
3.57
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
36.46
30.87
30.57
37.96
45.90
24.90
21.75
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
7.67
7.94
6.63
7.03
15.83
6.34
6.81
Sundry Debtors
18.66
18.66
19.42
23.50
24.90
13.74
11.28
Cash & Bank
1.61
1.13
0.38
2.36
0.91
0.58
-0.66
Other Current Assets
8.52
0.00
0.00
0.00
4.26
4.24
4.32
Short Term Loans & Adv.
4.51
3.14
4.14
5.07
4.24
4.19
4.26
Net Current Assets
-0.73
-5.58
1.66
6.95
5.01
0.01
-7.80
Total Assets
87.37
85.53
79.41
82.82
83.39
60.31
59.38

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
12.88
16.05
3.49
-0.25
-0.15
5.53
1.05
PBT
3.02
4.71
3.48
5.44
3.41
2.64
-5.16
Adjustment
9.60
8.78
3.04
3.00
2.34
1.94
1.90
Changes in Working Capital
0.91
3.91
-1.90
-6.63
-5.14
1.45
4.37
Cash after chg. in Working capital
13.53
17.40
4.62
1.81
0.61
6.04
1.10
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-0.65
-1.35
-1.13
-2.06
-0.76
-0.50
-0.05
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-5.18
-10.22
-6.18
-3.79
-5.77
-1.35
-1.59
Net Fixed Assets
6.02
9.34
0.32
-0.09
-0.15
-0.09
Net Investments
0.11
0.58
0.00
0.00
0.00
-0.02
Others
-11.31
-20.14
-6.50
-3.70
-5.62
-1.24
Cash from Financing Activity
-7.18
-5.45
0.72
5.50
6.25
-2.95
-0.74
Net Cash Inflow / Outflow
0.53
0.38
-1.97
1.45
0.33
1.23
-1.27
Opening Cash & Equivalents
0.43
0.05
2.36
0.91
0.58
-0.66
0.02
Closing Cash & Equivalent
0.96
0.43
0.38
2.36
0.91
0.58
-0.66

Financial Ratios

Standalone /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
38.23
36.88
32.50
29.55
24.55
21.62
21.17
ROA
1.22%
4.48%
3.09%
5.12%
3.47%
2.86%
-4.71%
ROE
3.31%
12.51%
9.50%
18.50%
12.70%
9.39%
-15.53%
ROCE
10.49%
13.73%
11.47%
16.35%
14.16%
14.03%
-1.95%
Fixed Asset Turnover
2.08
1.72
1.26
1.95
1.44
1.27
2.12
Receivable days
64.56
73.29
109.98
85.55
100.64
79.24
43.53
Inventory Days
27.01
28.05
35.01
40.41
57.75
41.63
26.26
Payable days
30.58
24.08
38.03
64.80
94.19
83.41
52.28
Cash Conversion Cycle
60.99
77.26
106.96
61.17
64.20
37.46
17.51
Total Debt/Equity
1.13
1.26
1.51
1.63
1.60
1.47
1.59
Interest Cover
1.70
1.96
1.81
2.24
1.93
1.69
-0.21

Top Investors:

dheeraj kumar lohia

Annual Reports:

FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011
FY 2010

News Update:


  • Parnax Lab - Quarterly Results
    14th Aug 2019, 18:13 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.